Metraipolis › archive › dc_3c30526df433

Association Between Body Mass Index and Treatment Toxicity in Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib or Pazopanib — Europe PMC PMID:42738252

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42738252
DOI
10.3390/cancers18172730
License (as archived)
solo-consultazione
Archived
2026-10-08T05:10:21.075Z
SHA-256 of the archived text
189949c9cdcb264c05fa2ecee7858b7ff4312e5977583fa795197cf14c934c60
Stable URL of this page
https://metraipolis.com/documento/dc_3c30526df433

How to cite

Association Between Body Mass Index and Treatment Toxicity in Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib or Pazopanib — Europe PMC PMID:42738252 — Europe PMC (en), https://europepmc.org/article/MED/42738252 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3c30526df433 (Metraipolis archive dc_3c30526df433, sha256 189949c9cdcb264c05fa2ecee7858b7ff4312e5977583fa795197cf14c934c60)
BibTeX
@misc{dc3c30526df433,
  title = {Association Between Body Mass Index and Treatment Toxicity in Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib or Pazopanib — Europe PMC PMID:42738252},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42738252},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3c30526df433; sha256 189949c9cdcb264c05fa2ecee7858b7ff4312e5977583fa795197cf14c934c60},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42738252. Agents can read the archived copy with the MCP tool read_document.